Clinical trial

18F-mFBG Cardiac Uptake With Lewy Body Dementia

NCT07176286

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-04-30

PhasePHASE2

Study timeline

Study start (actual)2026-04-30Date precision: day

Registry last updated2026-07-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Disease (PD)unresolved

Lewy Body Dementia (LBD)unresolved

Interventions

18F-MFBGDRUG

Sponsors & collaborators

Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)lead sponsor

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07176286 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.